Dr. Potarazu pleaded guilty to shareholder and employment fraud in December 2016. He admitted providing false and misleading information to VitalSpring’s shareholders to get them to make more than $49 million in capital investments in the company. For example, he told investors in 2014 that VitalSpring’s 2013 revenues were about $12.9 million when the company’s actual revenues for that year were less than $1 million. He also admitted concealing from shareholders that he failed to pay more than $7.5 million in employment taxes.
In May, VitalSpring, which provided data analysis and services related to healthcare expenditures, and its subsidiary Enziime filed for Chapter 7 bankruptcy.
More articles on legal and regulatory issues:
6 latest healthcare industry lawsuits, settlements
Lawsuits allege Memphis hospitals engage in illegal billing practices
DOJ charges 412 in $1.3B healthcare fraud sweep
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
